VIR
Vir Biotechnology Inc
10.60$
-2.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 41,954.4% | 11,547.1% | 20,122.6% | 394.9% | 46.9% | 38.4% | 664.7% | 645.0% | 17.1% | |
| -41,854.4% | -11,447.1% | 100.0% | 100.0% | 53.1% | 61.6% | -564.7% | -545.0% | 82.9% | |
| 41,954.4% | 11,547.1% | 20,882.1% | 396.0% | 40.9% | 29.4% | 672.7% | 682.6% | 631.3% | |
| 14,559.1% | 3,356.1% | 5,288.0% | 92.9% | 14.7% | 10.0% | 201.6% | 160.4% | 134.3% | |
| 54,796.0% | 13,774.2% | 25,132.2% | 488.9% | 14.7% | 10.0% | 229.4% | 246.2% | 765.6% | |
| -54,696.0% | -13,674.2% | -25,032.2% | -388.9% | 38.4% | 51.6% | -794.0% | -791.3% | -682.7% | |
| 0.0% | 0.0% | 1,120.5% | 5.0% | 24.9% | 11.3% | – | – | – | |
| -54,212.1% | -13,406.0% | -24,547.0% | -391.0% | 50.2% | 46.7% | -728.9% | -704.9% | -638.6% | |
| -7,331.5% | -55.3% | 21.7% | -0.1% | 1.9% | 14.8% | -15.2% | -1.5% | 0.3% | |
| -46,880.5% | -13,350.7% | -24,568.6% | -391.1% | 48.3% | 31.9% | -713.7% | -703.4% | -638.9% | |
| -54,406.0% | -13,356.7% | -24,396.9% | 673.5% | 50.7% | 47.1% | -744.5% | -685.8% | -621.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.